Clinical trial
Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin…
NCT00323219 · University of British Columbia, Other · Unknown status
Key facts
| NCT number | NCT00323219 |
|---|---|
| Title | Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency Department |
| Official title | Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency Department |
| Lead sponsor | University of British Columbia, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cellulitis |
| Intervention type | Drug |
| Interventions | Cefazolin and Moxifloxacin |
| Enrollment | 390 |
| Start date | Jan 1, 2004 |
| Primary completion | Dec 1, 2012 |
| Completion | Dec 1, 2013 |
| First posted | May 9, 2006 |
| Last update posted | Feb 8, 2012 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: